NO933421L - Konstrastmiddel - Google Patents

Konstrastmiddel

Info

Publication number
NO933421L
NO933421L NO933421A NO933421A NO933421L NO 933421 L NO933421 L NO 933421L NO 933421 A NO933421 A NO 933421A NO 933421 A NO933421 A NO 933421A NO 933421 L NO933421 L NO 933421L
Authority
NO
Norway
Prior art keywords
contrast
atoms
contrast agent
agent
contrast enhancing
Prior art date
Application number
NO933421A
Other languages
English (en)
Norwegian (no)
Other versions
NO933421D0 (no
Inventor
Torsten Almen
Arne Berg
C Allen Chang
Michael Droege
Harald Dugstad
Jere D Fellman
Sook Hui Kim
Jo Klaveness
Scott M Rocklage
Paal Rongved
Brent Segal
Alan D Watson
Original Assignee
Nycomed Salutar Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919106579A external-priority patent/GB9106579D0/en
Priority claimed from PCT/EP1992/000698 external-priority patent/WO1992017215A1/en
Application filed by Nycomed Salutar Inc filed Critical Nycomed Salutar Inc
Publication of NO933421D0 publication Critical patent/NO933421D0/no
Publication of NO933421L publication Critical patent/NO933421L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F11/00—Compounds containing elements of Groups 6 or 16 of the Periodic Table
    • C07F11/005—Compounds containing elements of Groups 6 or 16 of the Periodic Table compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02—Iron compounds
    • C07F15/025—Iron compounds without a metal-carbon linkage
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/903—Specified use of nanostructure for conversion, containment, or destruction of hazardous material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/927—Diagnostic contrast agent
    • Y10S977/928—X-ray agent
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/927—Diagnostic contrast agent
    • Y10S977/929—Ultrasound contrast agent

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Devices For Indicating Variable Information By Combining Individual Elements (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Liquid Crystal (AREA)
  • Materials For Medical Uses (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Lubricants (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
NO933421A 1991-03-27 1993-09-24 Konstrastmiddel NO933421L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919106579A GB9106579D0 (en) 1991-03-27 1991-03-27 Contrast media
GB919120507A GB9120507D0 (en) 1991-03-27 1991-09-26 Contrast media
PCT/EP1992/000698 WO1992017215A1 (en) 1990-03-28 1992-03-27 Contrast media

Publications (2)

Publication Number Publication Date
NO933421D0 NO933421D0 (no) 1993-09-24
NO933421L true NO933421L (no) 1993-11-24

Family

ID=26298647

Family Applications (1)

Application Number Title Priority Date Filing Date
NO933421A NO933421L (no) 1991-03-27 1993-09-24 Konstrastmiddel

Country Status (15)

Country Link
US (2) US5482699A (de)
EP (1) EP0577675B1 (de)
JP (1) JPH06506449A (de)
AT (1) ATE187340T1 (de)
AU (1) AU660013B2 (de)
CA (1) CA2106976A1 (de)
DE (1) DE69230400T2 (de)
ES (1) ES2138970T3 (de)
FI (1) FI934194A7 (de)
HU (1) HUT65240A (de)
IE (1) IE920996A1 (de)
NO (1) NO933421L (de)
NZ (1) NZ242156A (de)
PH (1) PH29904A (de)
SG (1) SG43930A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996019487A1 (en) * 1994-12-22 1996-06-27 Nissan Chemical Industries, Ltd. Organobismuth derivatives and process for producing the same
GB9501560D0 (en) * 1995-01-26 1995-03-15 Nycomed Imaging As Contrast agents
DE19507820A1 (de) * 1995-02-21 1996-08-22 Schering Ag Neuartig substituierte DTPA-Derivate, deren Metallkomplexe, diese Komplexe enthaltende pharmazeutische Mittel, deren Verwendung in der Diagnostik, sowie Verfahren zur Herstellung der Komplexe und Mittel
US5801228A (en) * 1995-06-07 1998-09-01 Nycomed Imaging As Polymeric contrast agents for medical imaging
US7745142B2 (en) * 1997-09-15 2010-06-29 Molecular Devices Corporation Molecular modification assays
US7070921B2 (en) 2000-04-28 2006-07-04 Molecular Devices Corporation Molecular modification assays
US7632651B2 (en) * 1997-09-15 2009-12-15 Mds Analytical Technologies (Us) Inc. Molecular modification assays
US20050227294A1 (en) * 1997-09-15 2005-10-13 Molecular Devices Corporation Molecular modification assays involving lipids
US7807137B1 (en) 1998-12-22 2010-10-05 University Of Puerto Rico Iron-based contrast agent
US6596259B1 (en) 1998-12-22 2003-07-22 University Of Puerto Rico Metal based cubane structure contained in an octanuclear complex stable over several oxidation states and a method of producing the same
US20030215391A1 (en) * 2001-07-19 2003-11-20 Carlos Rabito Fluorescent agents for real-time measurement of organ function
US20050106100A1 (en) * 2003-09-03 2005-05-19 Harris Thomas D. Compounds containing matrix metalloproteinase substrates and methods of their use
WO2006039505A2 (en) * 2004-09-30 2006-04-13 Molecular Devices Corporation Luminescent lanthanide complexes
US7888297B2 (en) * 2005-01-06 2011-02-15 Halliburton Energy Services, Inc. Compositions for reducing the viscosity of treatment fluids
WO2006084382A1 (en) * 2005-02-11 2006-08-17 University Health Network Compositions and methods for multimodal imaging
WO2007005491A1 (en) * 2005-06-30 2007-01-11 Bristol-Myers Squibb Pharma Company Hydrazide conjugates as imaging agents
US20120148501A1 (en) * 2010-12-08 2012-06-14 Fred Geisler Radiological image enhancement with tantalum clusters
JP6032729B2 (ja) * 2012-05-08 2016-11-30 国立研究開発法人理化学研究所 イメージングマーカーおよびその利用
CN104981475B (zh) * 2013-02-06 2018-10-26 Pom专利管理公司 杂多金属氧酸盐
CN114573609B (zh) * 2022-03-07 2024-02-06 桂林理工大学 一种基于不对称双核镝配合物的单分子磁体及其制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE130934C (de) *
DE263059C (de) *
DE361960C (de) * 1920-06-01 1922-10-20 Georg Spiess Rundstapelbogenanleger
US3860611A (en) * 1972-01-19 1975-01-14 Du Pont Macrocyclic polyether polyols and condensation polymers derived therefrom
US3763188A (en) * 1972-01-19 1973-10-02 Du Pont Spiro(1,1-polyethylenedi(oxymethyl))-3-oxetanes
US3952015A (en) * 1973-11-12 1976-04-20 Carl George Krespan Macrocyclic compounds having oxa and aza linkages in the ring and containing spirooxetane groups
US4079124A (en) * 1976-04-21 1978-03-14 Medi-Physics, Inc. Method of preparing X-ray contrast media containing ores of hafnium, tantalum and tungsten
US4176173A (en) * 1977-07-18 1979-11-27 Medi-Physics, Inc. Radiographic compositions
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
DE3324235A1 (de) * 1983-07-01 1985-01-10 Schering AG, 1000 Berlin und 4709 Bergkamen Neue komplexbildner, komplexe und komplexsalze
US4639365A (en) * 1984-10-18 1987-01-27 The Board Of Regents, The University Of Texas System Gadolinium chelates as NMR contrast agents
US4826673A (en) * 1985-01-09 1989-05-02 Mallinckrodt, Inc. Methods and compositions for enhancing magnetic resonance imaging
US4795698A (en) * 1985-10-04 1989-01-03 Immunicon Corporation Magnetic-polymer particles
IL83966A (en) * 1986-09-26 1992-03-29 Schering Ag Amides of aminopolycarboxylic acids and pharmaceutical compositions containing them
JP2833766B2 (ja) * 1987-07-16 1998-12-09 ニユコメド・アクシエセルカペト アミノポリカルボン酸およびその誘導体
FR2630547A1 (fr) * 1988-04-22 1989-10-27 Centre Nat Rech Scient Marquage froid de molecules de nature peptidique ou proteique
US5260050A (en) * 1988-09-29 1993-11-09 Ranney David F Methods and compositions for magnetic resonance imaging comprising superparamagnetic ferromagnetically coupled chromium complexes
US5213788A (en) * 1988-09-29 1993-05-25 Ranney David F Physically and chemically stabilized polyatomic clusters for magnetic resonance image and spectral enhancement
EP0361960A3 (de) * 1988-09-29 1992-01-02 RANNEY, David F. Verfahren und Vorrichtung zur Bilderzeugung mittels magnetischer Resonanz
GB9006977D0 (en) * 1990-03-28 1990-05-23 Nycomed As Compositions
GB9007967D0 (en) * 1990-04-09 1990-06-06 Nycomed As Compounds

Also Published As

Publication number Publication date
SG43930A1 (en) 1997-11-14
HUT65240A (en) 1994-05-02
NO933421D0 (no) 1993-09-24
DE69230400D1 (de) 2000-01-13
ATE187340T1 (de) 1999-12-15
IE920996A1 (en) 1992-10-07
FI934194L (fi) 1993-11-23
AU660013B2 (en) 1995-06-08
ES2138970T3 (es) 2000-02-01
AU1433892A (en) 1992-11-02
CA2106976A1 (en) 1992-09-28
FI934194A7 (fi) 1993-11-23
NZ242156A (en) 1994-07-26
JPH06506449A (ja) 1994-07-21
EP0577675A1 (de) 1994-01-12
US5932190A (en) 1999-08-03
PH29904A (en) 1996-09-16
US5482699A (en) 1996-01-09
DE69230400T2 (de) 2000-08-03
HU9302735D0 (en) 1993-12-28
FI934194A0 (fi) 1993-09-24
EP0577675B1 (de) 1999-12-08

Similar Documents

Publication Publication Date Title
NO933421L (no) Konstrastmiddel
NO923739L (no) Kontrastmidler
PL324342A1 (en) Complex compounds of a cascade polymer, method of obtaining them and pharmaceutic agents containing such compounds
EP0761166A3 (de) Dichtemessung von Knochen mittels Röntgenstrahlung
WO1996014878A3 (en) Calixarene conjugates useful as MRI and CT diagnostic imaging agents
NO972457L (no) Anvendelse av metallkomplekser som lever- og galleröntgendiagnostika i datatomografien
PL330828A1 (en) Carbohydrates containing insulin preparations
NO940410L (no) Anvendelse av inerte (persistente) frie radikaler i MRI
Blyth et al. Paratesticular rhabdomyosarcoma: results of therapy in 18 cases
AU8862891A (en) Chelating agents
WO1995019186A3 (en) Contrast media for x-ray and magnetic resonance imaging
GB8909270D0 (en) Method
SE9402880D0 (sv) New peptide derivatives
Thompson Cryogenic properties of copper
NZ332196A (en) A method for detection of potential co-antioxidants using electron paramagnetic resonance spectroscopy
Choi The present and prospect of standardization
Lee Practising Hospital Services during Preclinical School Years
Kim The methods of drive and approach of standardization
Ravery et al. Diagnostic improvement of prostate cancer using an extensive biopsy protocol
VITETTA GALLSTONE COMPOSITION AND DISSOLUTION.(VOLUMES I AND II)(BILIARY COLCULI, SLUDGE, CHOLECYSTECTOMY, AUTOPSY, CHOLELITHOLYSIS)
Mizuta et al. The includence and clinical significance of cholelithiasis after gastrectomy
Seo Recommendations for the Improvement of the Medical Licensing Examination
Wu et al. PATHOLOGICAL STUDIES OF CT FINDINGS IN SUPRATENTORIAL ASTROCYTOMA: CORRELATION BETWEEN LOW-DENSITY LESIONS AND CHANGES IN FINE STRUCTURE
CA2060330A1 (en) Compositions and method for soft tissue tumors
NEELS HUMAN ANGIOTENSIN CONVERTING ENZYME: DEVELOPMENT AND APPLICATION OF BIOANALYTICAL CONCEPTS (KINASE, KININASE)